← Russell 3000 cross-section

ICUI ICU MEDICAL INC/DE

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Healthcare

Scale

Market cap
$4.4bn
Revenue TTM
$2.2bn
Net income TTM
$30m
Free cash flow
$153m
Composite score
35.4
Sector rank
#1158

Valuation

P / E
146.8
EV / EBITDA
20.7
EV / sales
2.6
FCF yield
3.46%
Earnings yield vs 10-yr
-4.05pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
1.4%
EBITDA margin
12.7%
ROE
1.4%
ROIC
2.1%
Revenue growth
-9.0%

Insider activity, last 90 days

Net open-market
$-3.09m
Buyers
0
Sellers
4

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The total sales price, inclusive of our final purchase price adjustments, was $211.2 million, of which we used $200.0 million of the proceeds from the sale to pay down a portion of our outstanding Term Loan A (as defined below) long-term debt during the second quarter of 2025. Consumables The following table summarizes our total Consumables revenue (in millions, except percentages): Consumables revenue increased for the three and six months ended June 30, 2026, as compared to the same periods in the prior year. …ICU MEDICAL INC/DE, 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →